Treating diabetic retinopathy (DR ... the many who do not respond to current treatments. Pre-clinical results for its leading drug NG004, show a new mode of action and NovaGo plans to move ...

Diabetic retinopathy is a serious eye disease and ... hope to zero in on a new treatment pathway. They suspect the key to ...

“I think some of the new treatments will probably move the needle a little bit more in terms of treating this indication.” Ip MS. Update on the current treatment of diabetic retinopath ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Proliferative diabetic retinopathy is clinically characterized ... resulting in sudden and severe vision loss. New pharmacological treatments that avoid deleterious impacts on visual function ...

People with type 2 diabetes who are taking empagliflozin are less likely to develop diabetic retinopathy compared to those not using the drug, new evidence has revealed. A recent study from the ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative spearheaded by AIIMS. But AI hasn’t replaced doctors yet.

(HealthDay News) — Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR ... up period of 8 months receiving treatment, the risk for incident ...

These fragile new vessels leak fluid that collects ... until significant damage occurs. What are the treatment options available for diabetic retinopathy? Early stages may only require ongoing ...

Diabetic retinopathy involves the changes for the blood vessels in your eye due to the high sugars that are in your body from diabetes, if you're a diabetic and you notice changes to your vision ...